MPS Pharma Ltd. - Research Center
531686 ADVIKLA Group (XT) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 19.11 | 19.11 | 19.11 | 19.11 | 19.11 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | -16.32 | -15.29 | -15.16 | -10.75 | -9.58 |
| Loan funds | |||||
| Secured loans | 6.76 | 5.81 | 1.93 | 2.54 | 2.51 |
| Unsecured loans | - | - | - | - | - |
| Total | 9.56 | 9.63 | 5.88 | 10.90 | 12.03 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 15.84 | 15.72 | 15.71 | 16.05 | 16.16 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 11.70 | 11.55 | 11.04 | 10.79 | 10.28 |
| Net block | 4.14 | 4.17 | 4.68 | 5.26 | 5.88 |
| Capital work-in-progress | 3.40 | 3.42 | 3.90 | 5.02 | 5.43 |
| Investments | 0.54 | 0.54 | 0.54 | 0.92 | 0.92 |
| Net current assets | |||||
| Current assets, loans & advances | 2.10 | 2.03 | 2.19 | 5.21 | 5.32 |
| Less : current liabilities & provisions | 0.63 | 0.53 | 5.42 | 5.51 | 5.52 |
| Total net current assets | 1.47 | 1.50 | -3.23 | -0.30 | -0.20 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 9.56 | 9.63 | 5.88 | 10.90 | 12.03 |
| Notes: | |||||
| Book value of unquoted investments | - | - | - | - | - |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | - | - | 9.29 | 7.31 | 0.01 |
| Number of equity sharesoutstanding (Lacs) | 191.11 | 191.11 | 191.11 | 191.11 | 191.11 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis